CA2122827A1 - Implants sous-cutanes a base de derives du nomegestrol - Google Patents

Implants sous-cutanes a base de derives du nomegestrol

Info

Publication number
CA2122827A1
CA2122827A1 CA002122827A CA2122827A CA2122827A1 CA 2122827 A1 CA2122827 A1 CA 2122827A1 CA 002122827 A CA002122827 A CA 002122827A CA 2122827 A CA2122827 A CA 2122827A CA 2122827 A1 CA2122827 A1 CA 2122827A1
Authority
CA
Canada
Prior art keywords
pregna
alpha
methyl
composition according
implant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002122827A
Other languages
English (en)
French (fr)
Inventor
Michel Lanquetin
Jean-Louis Thomas
Jacques Paris
Elsimar Coutinho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Theramex SAM
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2122827A1 publication Critical patent/CA2122827A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
CA002122827A 1992-09-21 1993-09-17 Implants sous-cutanes a base de derives du nomegestrol Abandoned CA2122827A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR92/11422 1992-09-21
FR9211422A FR2695826B1 (fr) 1992-09-21 1992-09-21 Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
PCT/FR1993/000900 WO1994006437A1 (fr) 1992-09-21 1993-09-17 Implants sous-cutanes a base de derives de nomegestrol

Publications (1)

Publication Number Publication Date
CA2122827A1 true CA2122827A1 (fr) 1994-03-31

Family

ID=9433868

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002122827A Abandoned CA2122827A1 (fr) 1992-09-21 1993-09-17 Implants sous-cutanes a base de derives du nomegestrol

Country Status (31)

Country Link
US (1) US5565443A (enExample)
EP (1) EP0613372B1 (enExample)
JP (1) JPH08506318A (enExample)
KR (1) KR100255700B1 (enExample)
CN (1) CN1095667C (enExample)
AP (1) AP497A (enExample)
AT (1) ATE198275T1 (enExample)
AU (1) AU683423B2 (enExample)
BG (1) BG62317B1 (enExample)
BR (1) BR9305642A (enExample)
CA (1) CA2122827A1 (enExample)
CZ (1) CZ284806B6 (enExample)
DE (1) DE69329790D1 (enExample)
DZ (1) DZ1717A1 (enExample)
EC (1) ECSP930986A (enExample)
FI (1) FI942272A0 (enExample)
FR (1) FR2695826B1 (enExample)
HU (1) HUT67044A (enExample)
IL (1) IL107039A (enExample)
MA (1) MA22978A1 (enExample)
NO (1) NO306238B1 (enExample)
OA (1) OA09924A (enExample)
PL (1) PL176120B1 (enExample)
RO (1) RO115783B1 (enExample)
RU (1) RU2120797C1 (enExample)
SK (1) SK54694A3 (enExample)
TN (1) TNSN93104A1 (enExample)
TW (1) TW381024B (enExample)
WO (1) WO1994006437A1 (enExample)
YU (1) YU60493A (enExample)
ZA (1) ZA936964B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
GB2355728A (en) * 1999-10-27 2001-05-02 Anson Medical Ltd Tubular medical implants and methods of manufacture
CA2418135C (en) 2000-08-03 2011-09-20 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
ES2385030T3 (es) 2001-06-29 2012-07-17 Medgraft Microtech, Inc. Implantes inyectables biodegradables y procedimientos relacionados con su fabricación y uso
PT2561860T (pt) * 2002-05-31 2018-05-08 Titan Pharmaceuticals Inc Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
SI1610791T1 (sl) * 2003-03-31 2011-05-31 Titan Pharmaceuticals Inc Implantibilna polimerna naprava za zadržano sproščanje dopaminskega agonista
US20050031668A1 (en) * 2003-05-30 2005-02-10 Patel Rajesh A. Implantable polymeric device for sustained release of nalmefene
CA2538856C (en) 2003-10-10 2010-06-29 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
ES2432556T3 (es) 2004-08-04 2013-12-04 Evonik Corporation Métodos para fabricar dispositivos de suministro y sus dispositivos
WO2007124250A2 (en) 2006-04-21 2007-11-01 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
FR2904213B1 (fr) * 2006-07-27 2008-10-10 Creaspine Soc Par Actions Simp Implant intervertebral destine a la fusion osseuse
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant
US12582767B2 (en) 2021-12-30 2026-03-24 Taiyo Weber Compressible, minimally invasive implants and related systems and methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147783A (en) * 1974-02-28 1979-04-03 Akzona Incorporated Oral pharmaceutical preparation
GB1515284A (en) * 1974-05-21 1978-06-21 Gastaud J Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
US4172132A (en) * 1977-07-26 1979-10-23 Schering Corporation 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
HU182775B (en) * 1981-10-15 1984-03-28 Richter Gedeon Vegyeszet Process for preparing new 3-chloro-pregnane derivatives
US5223492A (en) * 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them
FR2664895B1 (fr) * 1990-07-20 1992-10-30 Theramex Laboratoire Nouveaux derives de la 6-methyl 19-nor progesterone, substitues en 3 et leur procede d'obtention.

Also Published As

Publication number Publication date
AP497A (en) 1996-05-28
YU60493A (sh) 1997-01-08
CZ116494A3 (en) 1995-03-15
PL176120B1 (pl) 1999-04-30
HU9401395D0 (en) 1994-08-29
IL107039A0 (en) 1993-12-28
EP0613372A1 (fr) 1994-09-07
CN1094284A (zh) 1994-11-02
RU2120797C1 (ru) 1998-10-27
US5565443A (en) 1996-10-15
WO1994006437A1 (fr) 1994-03-31
TNSN93104A1 (fr) 1994-03-17
FI942272A7 (fi) 1994-05-16
JPH08506318A (ja) 1996-07-09
NO941900L (no) 1994-05-24
ZA936964B (en) 1994-04-14
BG98776A (bg) 1995-02-28
BR9305642A (pt) 1996-01-09
MA22978A1 (fr) 1994-04-01
SK54694A3 (en) 1994-10-05
CZ284806B6 (cs) 1999-03-17
ECSP930986A (es) 1994-04-12
AP9300576A0 (enExample) 1993-10-31
HUT67044A (en) 1995-01-30
NO941900D0 (no) 1994-05-20
NO306238B1 (no) 1999-10-11
OA09924A (fr) 1994-09-15
RO115783B1 (ro) 2000-06-30
ATE198275T1 (de) 2001-01-15
AU4822993A (en) 1994-04-12
FI942272L (fi) 1994-05-16
KR100255700B1 (ko) 2000-08-01
FR2695826B1 (fr) 1995-01-06
IL107039A (en) 1999-01-26
CN1095667C (zh) 2002-12-11
BG62317B1 (bg) 1999-08-31
TW381024B (en) 2000-02-01
FI942272A0 (fi) 1994-05-16
EP0613372B1 (fr) 2000-12-27
DE69329790D1 (de) 2001-02-01
DZ1717A1 (fr) 2002-02-17
AU683423B2 (en) 1997-11-13
FR2695826A1 (fr) 1994-03-25

Similar Documents

Publication Publication Date Title
EP0613372B1 (fr) Implants sous-cutanes a base de derives de nomegestrol
EP0123585B1 (fr) Nouvelle forme transdermale de médicaments
EP0776659B1 (fr) Dispositif de délivrance de médicaments par voie intravaginale
KR101229701B1 (ko) 프로게스테론 수용체 조절제를 함유하는 서방형 조성물
JP2547151B2 (ja) 経皮組成物
JP4895150B2 (ja) 抗黄体ホルモン特性を有する薬物を送達するための器具
CA2243274C (en) Male contraceptive implant
FR2569107A1 (fr) Suppositoires antifongiques adhesifs a longue duree
FR2653338A1 (fr) Formulation pour des pansements a liberation prolongee de medicament et son utilisation.
EA018112B1 (ru) Вагинальная система доставки
FR2653337A1 (fr) Element a liberation prolongee et procede pour le fabriquer.
FR2551976A1 (fr) Hydrogels polymeres a microphases separees pour la liberation commandee de matieres, notamment bioactives
FR2717689A1 (fr) Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base de copolymère styrène-isoprène-styrène.
EP0639069A1 (fr) Forme galenique pour administration oculaire et procede de preparation.
WO1997011689A1 (fr) Systeme matriciel transdermique
CN1835737A (zh) 由雌二醇和胆固醇组成的稳定形状颗粒的制备方法
JP2003521456A (ja) ドラッグデリバリーデバイス、特にアンドロゲンデリバリーデバイス
BE1000266A5 (fr) Preparations pharmaceutiques en suppositoires bioadhesives et leur utilisation.
OA10411A (fr) Nouveaux médicaments hormonaux et leur utilisation pour la correction des carences estrogéniques
FR2693109A1 (fr) Pâte adhésive thixotrope pour la protection de la peau, son procédé de préparation et ses applications .

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued